Up-and-Coming Lawyers at Dallas Plaintiffs Firm Hamilton Wingo Earn 2024 Texas Rising Stars Selections
DALLAS, April 2, 2024 /PRNewswire/ — Four up-and-coming attorneys from the Dallas plaintiffs’ law firm Hamilton Wingo are recognized on the 2024 Texas Rising Stars for their work in personal injury lawsuits and other civil cases. The annual guide published by Thomson Reuters includes fe
M.D.C. Holdings Stockholders Approve Transaction with Sekisui House
DENVER, April 2, 2024 /PRNewswire/ — M.D.C. Holdings, Inc. (“MDC”) (NYSE: MDC), today announced that its stockholders have approved a proposal to adopt the merger agreement entered into between MDC and Sekisui House, Ltd. (“Sekisui House”) at its Special Meeting of Sto
Jukebox Health Partners with Sonder Health to Administer Home Safety & Accessibility Modifications As A Benefit in 2024
Jukebox Health partners with Sonder Health to make in-home evaluations & fall prevention solutions available to thousands of eligible Medicare Advantage members. NEW YORK, April 2, 2024 /PRNewswire/ — Today Jukebox Health, a national provider of home and community based services that depl
Spectra Systems Commercializes the World’s First Certified Circular Polymer Banknote Substrate
Guaranteeing the world’s central banks and the public that their currency is part of an audited mass-balanced recycled plastics supply chain PROVIDENCE, R.I., April 2, 2024 /PRNewswire/ — Over the last several decades many central banks have utilized polymer substrates rather than paper
ViaLase to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
ALISA VIEJO, Calif., April 2, 2024 /PRNewswire/ — ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it will present clinical data as well as provide a business and technology over
Convergent Therapeutics Announces FDA Clearance of IND Application for CONV01-α, a Best-in-Class Radioantibody Targeting Prostate-Specific Membrane Antigen
– CONV01-α is an actinium-225 labeled radioantibody with proven efficacy and safety in multiple Phase 1/2 trials in prostate cancer patients – Convergent Therapeutics will conduct Phase 2 clinical trials in 2024 preparing for a registrational program in 2025 CAMBRIDGE, Mass., April
Stephen F. Austin State University hires Cardinal Grange search firm to take athletics program to next level
Cardinal Grange brings incomparable expertise to deliver top tier AD NEW YORK, April 2, 2024 /PRNewswire/ — Today, professional search firm Cardinal Grange announced that Stephen F. Austin State University has hired the firm to guide the hiring process for a new athletic director. SFA has als
The Dairy Alliance Supports Runners at Cooper River Bridge Run Expo
Highlights dairy milk’s performance benefits and advocates for #TEAMMILK, April 4 -5 CHARLESTON, S.C., April 2, 2024 /PRNewswire/ — The Dairy Alliance, a nonprofit funded by dairy farmers in the Southeast, is heading to the races and will be supporting the Cooper River Bridge Run Expo in
Matrix HG Works with The Menke Group to Adopt the Employee Ownership Model with an Employee Stock Ownership Plan (ESOP)
SAN MATEO, Calif., April 2, 2024 /PRNewswire/ — The Menke Group, a leading full-service ESOP provider, announced that Matrix HG, a Concord-based innovator serving the San Francisco Bay Area with commercial HVAC systems, has become 100 percent employee-owned with the help of The Menke Group. T
Decision Notice – CIRO Hearing Panel issues Reasons for Decision in the matter of Lifan Song
WINNIPEG, MB, April 2, 2024 /CNW/ – Following a settlement hearing held on February 6, 2024 pursuant to the Mutual Fund Dealer Rules, a hearing panel of the Canadian Investment Regulatory Organization (CIRO) found that Lifan Song failed to report to the Dealer Member complaints that he receiv